For: | Ahn HM, Kim DW, Oh HJ, Kim HK, Lee HS, Lee TG, Shin HR, Yang IJ, Lee J, Suh JW, Oh HK, Kang SB. Different oncological features of colorectal cancer codon-specific KRAS mutations: Not codon 13 but codon 12 have prognostic value. World J Gastroenterol 2023; 29(32): 4883-4899 [PMID: PMC10494767 DOI: 10.3748/wjg.v29.i32.4883] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i32/4883.htm |
Number | Citing Articles |
1 |
José Luis Venegas-Rodríguez, Jesús Arturo Hernández-Sandoval, Melva Gutiérrez-Angulo, José Miguel Moreno-Ortiz, Anahí González-Mercado, Jorge Peregrina-Sandoval, Helen Haydee Fernanda Ramírez-Plascencia, Beatriz Armida Flores-López, Carlos Rogelio Alvizo-Rodríguez, Jesús Alonso Valenzuela-Pérez, Sergio Cervantes-Ortiz, María de la Luz Ayala-Madrigal. KRAS Exon 2 Mutations in Patients with Sporadic Colorectal Cancer: Prevalence Variations in Mexican and Latin American Populations. Cancers 2024; 16(13): 2323 doi: 10.3390/cancers16132323
|
2 |
Wen-Yu Luan, Hao Lin, Yan-Dong Miao. Recommendations for articles and reviews in colorectal cancer-related research at the year-end of 2023. World Journal of Gastroenterology 2024; 30(30): 3548-3553 doi: 10.3748/wjg.v30.i30.3548
|
3 |
Zhiyan Jiang, Yan Li, Xin Zhou, Jie Wen, Pengwu Zheng, Wufu Zhu. Research progress on small molecule inhibitors targeting KRAS G12C with acrylamide structure and the strategies for solving KRAS inhibitor resistance. Bioorganic & Medicinal Chemistry 2024; 100: 117627 doi: 10.1016/j.bmc.2024.117627
|
4 |
Shengbin Zheng, Zhijie You, Guodon Guo, Zhijing Lin, Siming Wang, Guohua Yang. Effect of KRAS mutation status on clinicopathological characteristics and overall survival in patients with rectal cancer. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03615-6
|
5 |
Pieterjan Vanclooster, Sofie Seghers, Hans Prenen. State-of-the-art and upcoming trends in RAS-directed therapies in gastrointestinal malignancies. Current Opinion in Oncology 2024; 36(4): 313 doi: 10.1097/CCO.0000000000001042
|